← Back to Directory

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Details

Price & Market Data

Price: $2.43

Daily Change: $0.00 / 0.00%

Daily Range: $2.43 - $2.43

Market Cap: $9,124,524,032

Daily Volume: 100

Performance Metrics

1 Week: -6.73%

1 Month: -1.22%

3 Months: -7.09%

6 Months: -26.52%

1 Year: 24.68%

YTD: -12.77%

About Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)

Your daily market report for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF). Price: 2.43, daily change: $0.00 / 0.00%. Market cap: 9,124,524,032. Full performance analysis from YTD to 52-week.

Company Details

Employees: 40603

Sector: Health technology

Industry: Pharmaceuticals: major

Country: China

Details

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Selected stocks

Edgewater Wireless Systems, Inc. (KPIFF)

Potash America, Inc. (PTAM)

Life360 Inc. (LIFX)

IONIK CORP. (INIKF)

DOMINION RES BLACK WARRIOR TST (DOMR)